Skip to content
GLP-1 Decoder

New Mexico Medicaid GLP-1 Coverage: Wegovy, Zepbound

Not for weight loss. New Mexico Medicaid covers GLP-1s only for type 2 diabetes and other approved uses. New Mexico Medicaid does not cover GLP-1s for weight loss, though it covers some older weight-loss drugs. GLP-1s are covered for type 2 diabetes and other approved uses.

For weight loss
Not covered
For type 2 diabetes
Covered
Weight loss, KFF survey January 2026
Not covered

Does New Mexico Medicaid cover GLP-1s?

Sources: KFF 1 2 3.

By drug: Wegovy, Zepbound, Ozempic, Mounjaro

GLP-1 drugs in New Mexico Medicaid
MedicineMain useIn New Mexico MedicaidEvery state
WegovyWeight lossNot coveredWegovy and Medicaid
ZepboundWeight lossNot coveredZepbound and Medicaid
FoundayoWeight lossNot coveredNot listed
SaxendaWeight lossNot coveredSaxenda and Medicaid
OzempicType 2 diabetesCovered for type 2 diabetesOzempic and Medicaid
MounjaroType 2 diabetesCovered for type 2 diabetesMounjaro and Medicaid
RybelsusType 2 diabetesCovered for type 2 diabetesRybelsus and Medicaid
TrulicityType 2 diabetesCovered for type 2 diabetesTrulicity and Medicaid
VictozaType 2 diabetesCovered for type 2 diabetesVictoza and Medicaid

Sources: KFF.

Prior authorization rules

Source: KFF.

How to check your plan

  1. Look for the drug on the state list: New Mexico Medicaid drug list.
  2. When your Medicaid is managed by a managed care plan, ask if the drug requires prior authorization. Use the member number on your card.
  3. Find out from your prescriber which GLP-1 is preferred, since approval is faster for preferred drugs.
  4. Save the decision notice, whether it says approval or denial. It identifies the rule that applies to you.

Which brand pages are relevant to New Mexico

If New Mexico Medicaid says no to coverage

If coverage says no
MedicineLowest self-payManufacturer offer if your plan does not cover the drug
Wegovy$149 a monthNot listed
Zepbound$299 a month$299 a month
Foundayo$149 a monthNot listed

Sources: foundayo.lilly.com, TrumpRx, NovoCare, CMS.